About US
Contact us
-
U.S. questions India's IP regime after Nexavar moveIs intellectual property safe in India? That's the question drugmakers--and now U.S. officials--are asking, as the country's top court considers a landmark patent case, and after the government ordere2012/3/28
-
Arkansas jury hears state's claims against J&JAs a trial over Johnson & Johnson's ($JNJ) Risperdal marketing opens in Arkansas, the state's lawyers contend that company officials misled doctors about the atypical antipsychotic, defrauding Med2012/3/28
-
Roche to offer cancer drugs in India at deep discountsJust days after officials in India stripped Bayer ($BAY) of its exclusive rights to Nexavar, giving a local company the right to produce it at a deep discount, Roche ($RHHBY) has stepped up with plans2012/3/27
-
SFDA Commissioner Yin Li and Deputy Commissioner Bian Zhenjia meet with European Commissioner for Health and Consumer Policy and Director General of European Commission DG Health and ConsumersOn March 20, 2012, Yin Li, Commissioner of the State Food and Drug Administration (SFDA) and SFDA Deputy Commissioner Bian Zhenjia met with the visiting John Dalli, European Commissioner for Health an2012/3/27
-
FDA seeks advice on making more drugs OTCThere is more talk in Washington, D.C., about stretching the definition of over-the-counter. The FDA is holding its second day of hearings on whether some prescription medications should be sold OTC2012/3/26
-
SFDA issues Requirements on the Naming of Health Food and Guide to the Naming of Health FoodIn order to ensure scientific and standard naming of health foods and protect the legitimate rights and interests of consumers, the State Food and Drug Administration (SFDA) revised the Requirements o2012/3/26
-
Study: No reason teens can't buy emergency contraception OTCGirls younger than 17 can safely use emergency contraception without a prescription, and there is no reason they can't buy it over-the-counter. At least that's the conclusion from a study whose final2012/3/23
-
GSK to build new U.K. site, create up to 1,000 jobsGood news for the U.K. coming from GlaxoSmithKline ($GSK)today. The pharma giant said it will build a new facility in Ulverston, Cumbria--its first new U.K. facility in about 40 years--to boost produc2012/3/23
-
Pharma sales execs: Current model is broken; changes are comingPharma sales and marketing execs are pessimistic about the way things are being done. In fact, a recent Booz & Company and National Analysts Worldwidesurvey found 68% of these execs believe the cu2012/3/22
-
FDA panel backs GSK's Votrient for soft-tissue sarcomaGood news came for GlaxoSmithKline ($GSK) Tuesday after the FDA's Oncologic Drugs Advisory Committee voted 11-2 in favor of approving Votrient to treatpatients with advanced soft-tissue sarcoma who ha2012/3/22